In Brief: Taro
This article was originally published in The Tan Sheet
Executive Summary
Taro: Receives U.S. approval of ANDA for 2% miconazole nitrate vaginal cream through its subsidiary, Taro Pharmaceuticals, Inc. of Ontario, Canada. The cream, which is equivalent to Ortho's Monistat-7, will be available for private label sale within two months and also will retail under the Taro name...